Concepedia
Statistics
Publications
28
Citations
2.1K
H-Index
23
Active since
1984
Affiliations
Eli Lilly (United States)(Current)
The Ohio State University
The Ohio State University Wexner Medical Center
National Institutes of Health
Karen L. Cox is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and immunology.
Top concepts
MedicineImmunologyPharmacologyMolecular BiologyBiosynthesisMicrobiologyTumor BiologyDrug DiscoveryOncologyBacteriology
Publications per year
1984–2020
Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity
Jeremy R. Graff, Bruce W. Konicek, Thomas M. Vincent et al. · Journal of Clinical Investigation · 2007 · 375 citations · Full text
Tumor Biology, Therapeutic Suppression, Medicine +12
A Comparison of Assay Performance Measures in Screening Assays: Signal Window, Z′ Factor, and Assay Variability Ratio
Philip W. Iversen, Brian J. Eastwood, G. Sitta Sittampalam et al. · SLAS DISCOVERY · 2006 · 241 citations
Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein
A. Meyer, Jacqueline Benson, Ingrid E. Gienapp et al. · The Journal of Immunology · 1996 · 111 citations · Full text
Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance
Dominik Aschenbrenner, Maria Quaranta, Soumya Banerjee et al. · Gut · 2020 · 110 citations · Full text
Characterization and preclinical development of LY2603618: a selective and potent Chk1 inhibitor
Constance King, Henry Diaz, Darlene Barnard et al. · Investigational New Drugs · 2013 · 109 citations
Molecular Pharmacology, Drug Target, Preclinical Development +8
1–5 of 28